Life Science Investment Fund focused on the most promising new breakthrough drugs
Bringing Dramatic Advances
in the Biotechnology Sector
Aquilo Capital invests in drug development companies that harness the power of cutting-edge science to address urgent medical needs. We employ deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies.
Expanding European Opportunity
The unique evolution of research in the European landscape has created a scaffold for quality innovation, resilience, and the resources to deliver results efficiently
Long History and Reputable Track Record
We have a long history and track record of achieving strong absolute return for our partners while investing in important new medicines for large unmet medical needs.
We Translate Opportunities Into Scientific Breakthroughs
*Securities highlighted or discussed above have been selected to illustrate Aquilo Capital Management, LLC’s (“Aquilo”) investment approach and/or market outlook and are not intended to represent the performance of Aquilo’s clients or indicator for how Aquilo’s clients have performed or may perform in the future. Each listed security was selected solely for this purpose and has not been selected on the basis of performance or any performance-related criteria. The securities discussed herein do not represent an entire portfolio and in the aggregate may only represent a small percentage of a clients’ holdings. Aquilo’s clients’ portfolios are actively managed and securities discussed may or may not be held in such portfolios at any given time. Nothing on this webpage shall constitute a recommendation or endorsement to buy or sell any security or other financial instrument referenced herein.